A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Evans, Kurt W KW; Yuca, Erkan E; Akcakanat, Argun A; Scott, Stephen M SM; Arango, Natalia Paez NP; Zheng, Xiaofeng X; Chen, Ken K; Tapia, Coya C; Tarco, Emily E; Eterovic, Agda K AK; Black, Dalliah M DM; Litton, Jennifer K JK; Yap, Timothy A TA; Tripathy, Debu D; Mills, Gordon B GB; Meric-Bernstam, Funda F